ReviewTropical medicine and infectious disease2017
Heterogeneity of Rabies Vaccination Recommendations across Asia.
Review in Tropical medicine and infectious disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study.Human vaccines & immunotherapeutics · 2021Trial
- The impact of media on surge capacity in emergency departments: a study on rabies vaccination uptake.BMC emergency medicine · 2025Article
- Randomized Controlled Trial of the Immunogenicity and Safety of a Serum-Free Purified Vero Rabies Vaccine (PVRV-NG2) Using a Simulated Postexposure Zagreb Regimen With Human Rabies Immunoglobulin in Adults in Thailand.Open forum infectious diseases · 2024Article
- One-dose intradermal rabies booster enhances rabies antibody production and avidity maturation.Medical microbiology and immunology · 2024Article
- Post-Exposure Prophylactic Vaccination against Rabies: A Systematic Review.Iranian journal of public health · 2022Review
- Knowledge, attitude, and practice of a local community towards the prevention and control of rabies in Gaibandha, Bangladesh.Journal of advanced veterinary and animal research · 2020Article
- Fight against rabies in Nepal: Immediate need for government intervention.One health (Amsterdam, Netherlands) · 2020Article
- Purified Vero Cell Rabies Vaccine (PVRV, VerorabTropical medicine and infectious disease · 2020Review
- Circumstances of human conflicts with bears and patterns of bear maul injuries in Bhutan: Review of records 2015-2019.PloS one · 2020Article
- Cost Savings of Using Updated Thai Red Cross Intradermal Regimen in a High-Throughput Anti-Rabies Clinic in New Delhi, India.Tropical medicine and infectious disease · 2019Article
- Special Issue: Rabies Symptoms, Diagnosis, Prophylaxis, and Treatment.Tropical medicine and infectious disease · 2017Article
- Community awareness, perception, and preventive practices towards rabies in Ethiopia: A systematic review and meta-analysis.Therapeutic advances in infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asian countries bear the greatest burden of the disease, with a majority (59%) of rabies-related deaths occurring in Asia. In order to promote best practices, we summarized national human vaccination guidelines across this region, to highlight differences and similarities and to discuss the aspects that would benefit from updates. National management guidelines for rabies were retrieved from various sources to extract information on rabies pre- and post-exposure prophylaxis (PrEP, and PEP), booster vaccination, and route of administration. Rabies guidelines recommendations for wound management and PrEP across Asia are broadly aligned to the World Health Organization (WHO) guidelines. For PEP, the 5-dose Essen, and the 4-dose Zagreb are the regimens of choice for intramuscular (IM), and the Thai Red Cross regimen for intradermal (ID), administration. Several national guidelines have yet to endorse ID vaccine administration. Most guidelines recommend rabies immunoglobulin in category III exposures. Booster recommendations are not included in all guidelines, with limited clarity on booster requirement across the spectrum of risk of rabies exposure. In conclusion, national recommendations across Asian countries differ and while some guidelines are closely aligned to the WHO recommendations, resource-saving ID administration and use of rational abbreviated schedules have yet to be endorsed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.